Back to search
Osteoarthritis in Postmenopausal Women
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Osteoarthritis in Postmenopausal Women trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Osteoarthritis in Postmenopausal Women trials you may qualify forToday, osteoarthritis (OA) is considered a whole-organ disease that is amenable to prevention and treatment in the early stages. Information on the articular ca…
This study is designed as a randomized, double-blind, placebo-controlled clinical trial with two parallel groups. All participants will receive a standardized p…
Osteoarthritis (OA) is a degenerative joint disease that primarily affects the knees and becomes more prevalent with age. In individuals over 50, particularly t…
the aim of this study is to investigate the efficacy of Combination Therapy on Knee Osteoarthritis Pain in Postmenopausal Women
Post-menopausal women aged 40-65 with symptomatic hand osteoarthritis are invited to take part in this feasibility study. The study's aim is to investigate whet…
The primary objective of this study is to determine the incidence of modeling-based bone formation in the femoral neck in participants who have received denosum…
This randomized clinical trial will evaluate the efficacy of an antiresorptive osteoporosis drug (denosumab) in prevention of periprosthetic bone loss and in pr…
Osteoarthritis (OA) and osteoporosis (OP) affect large numbers of the population. Around 8 million people in the UK are affected by OA and over 300,000 people p…